Skip to main content
. 2008 Jan 23;2008(1):CD005171. doi: 10.1002/14651858.CD005171.pub2
Methods Trial with both randomised and open label arms
Participants Bipolar disorder and schizoaffective disorder
Interventions 8 on oxcarbazepine, 7 on lithium. 5 of these were open label
Outcomes Relapse of disorder
Notes 33 month study . Method of randomisation was not clear. Method of analysing open label patients, if analysed separately, from randomised group was not described.
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? High risk C ‐ Inadequate